Transdermal nitroglycerin to reduce the incidence of neonatal mortality in women who present in preterm labour: a placebo-controlled randomised trial

Queen's University (Canada)0 个研究点目标入组 600 人开始时间: 2005年9月26日最近更新: 2015年1月13日

试验速览

暂无简介。

•1. Greater than or equal to 24 to less than or equal to 32 weeks gestational age based on menstrual dates or earliest ultrasound scan
•2. Preterm labour:
•2.1. At least four painful uterine contractions per 20 minutes
•2.2. Change in the cervix (change in bishop score or bishop score greater than or equal to 6)

•1. Any maternal (e.g. significant antepartum haemorrhage) or foetal (e.g. non-reassuring heart rate pattern) condition necessitating immediate delivery
•2. Multiple gestations (i.e. twins, triplets etc.)
•3. Premature prelabour rupture of the membranes (PPROM)
•4. Intrauterine foetal demise or lethal foetal anomalies
•5. Cervix dilated greater than 8 cm
•6. Treatment with another agent within 24 hours
•7. Previous enrolment in this trial
•8. Known sensitivity to GTN
•9. Failure to give consent

发起方

Queen's University (Canada)